Type to search

Gracell Biotechnologies Appoints Accomplished Clinical Leader Dr. Wendy Li as Chief Medical Officer | Pharmtech Focus
Gracell Biotechnologies Doses First Patients in First-in-Human Clinical Trial Evaluating GC012F, its Dual-Targeting FasTCAR-T Therapy, in B-Cell Non-Hodgkin’s Lymphoma | Pharmtech Focus
Gracell Biotechnologies Unveils Innovation Center in U.S. | Pharmtech Focus